Diabetes Kongress 2023
zur Liste
Dr. rer. nat. Jennifer Lühr
GSK GmbH & Co. KG Germany
  • Vortrag A Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3-OA) is Efficacious in Adults ≥ 60 Years of Age (YOA) Speaker
    Datum: 19.05.2023 , Zeit: 11:19 | Thema: Poster
    Details